Skip to search formSkip to main contentSkip to account menu

recurrent bladder cancer

Known as: Recurrent Cancer of Bladder, Relapsed Cancer of Bladder, cancer of the bladder, recurrent 
The reemergence of bladder carcinoma after a period of remission.
National Institutes of Health

Related topics

Related topics

9 relations
Epithelial CellsEpitheliumHematuriaMalignant Epithelial Cell

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2016
Review
2016
Perineal herniation of an ileal neobladder following radical cystectomy and consecutive rectal resection for recurrent bladder carcinoma.
Secondary perineal herniation of intraperitoneal contents represents a rare complication following procedures such as… 
Highly Cited
2014
Highly Cited
2014
Urinary Protein Biomarker Panel for the Detection of Recurrent Bladder Cancer
Background: Up to 70% of patients with non–muscle-invasive bladder cancer (NMIBC) experience disease recurrence, making it one of… 
Highly Cited
2013
Highly Cited
2013
A 3-Plex Methylation Assay Combined with the FGFR3 Mutation Assay Sensitively Detects Recurrent Bladder Cancer in Voided Urine
Purpose: DNA methylation is associated with bladder cancer and these modifications could serve as useful biomarkers. FGFR3… 
Highly Cited
2009
Highly Cited
2009
An individual patient data meta-analysis of the long-term outcome of randomised studies comparing intravesical mitomycin C versus bacillus Calmette-Guérin for non-muscle-invasive bladder cancer
incidence estimates in the BCG group (p=0.005). There was a weak trend for fewer progressions (p=0.1) and cancer-specific deaths… 
Highly Cited
2008
Highly Cited
2008
Risk factors for intravesical recurrence after surgical management of transitional cell carcinoma of the upper urinary tract.
Highly Cited
2001
Highly Cited
2001
Microsatellite analysis—DNA test in urine competes with cystoscopy in follow‐up of superficial bladder carcinoma
It has been shown that microsatellite analysis (MA) is able to detect bladder carcinoma in urine. Relatively small groups of… 
Review
2000
Review
2000
Management of superficial transitional cell carcinoma in the intramural ureter: what to do?
2000
2000
Urinary tissue factor levels in patients with bladder and prostate cancer.
AIMS Coagulation activation is a recognized complication of cancer in which increased tissue factor (TF) is implicated. TF can be… 
Highly Cited
1997
Highly Cited
1997
Evaluation of the telomeric repeat amplification protocol (TRAP) assay for telomerase as a diagnostic modality in recurrent bladder cancer.
There is a need for the identification of an accurate test for the detection of recurrent bladder cancer. In this study, we… 
Review
1994
Review
1994
Prognosis and treatment of T1G3 bladder tumours. A prognostic factor analysis of 121 patients
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)